NextGen Healthcare (NASDAQ:NXGN) reported Q1 EPS of $0.16, in-line with the analyst estimate of $0.16. Revenue for the quarter came in at $153.3 million versus the consensus estimate of $152.89 million.
GUIDANCE:
NextGen Healthcare sees FY2023 EPS of $0.92-$0.98, versus the consensus of $0.98. NextGen Healthcare sees FY2023 revenue of $621-633 million, versus the consensus of $634 million.